Cited by 29Muscle metabolism and nutritionPharmacovigilance and Adverse Drug ReactionsNutrition and Health Studies

Safety of creatine supplementation: analysis of the prevalence of reported side effects in clinical trials and adverse event reports

Open access
Kreider, Richard B., Gonzalez, Drew E., Hines, Kelly, Gil, Adriana, Bonilla, Diego A.·2025·Journal of the International Society of Sports Nutrition

Abstract

Background Individual studies have indicated that creatine supplementation is generally well tolerated and not associated with clinically significant side effects. Nevertheless, anecdotal reports about side effects persist primarily from popular and social media and on the Internet.Methods This study evaluated side effects reported from 685 human clinical trials on creatine supplementation, worldwide adverse event report (AER) databases, and performed a social media sentiment analysis. The presence of side effects (No, Yes) in studies was evaluated using chi-squared analysis. The frequency of side effects among study participants was evaluated using a multivariate analysis of variance.Results A total of 13,452 participants in 652 studies ingested placebos (PLA), while 12,839 participants in 685 studies consumed creatine (Cr). Nearly all studies (95%) provided CrM at an average dose of 0.166 [0.159, 0.173] g/kg/d (about 12.5 g/d) for 64.7 [52.0, 77.3] days in studies lasting up to 14 yrs. Side effects were reported in 13.2% of studies in the PLA groups and 13.7% of studies in the Cr-supplemented groups, with no significant differences observed between the groups (p = 0.776). There was a slightly higher percentage of studies reporting gastrointestinal (GI) issues (PLA 4.3%, Cr 4.9%, p < 0.001) and muscle cramping/pain (PLA 0.9%, Cr 2.9%, p = 0.008) with Cr supplementation, but not when the total number of participants in these studies was evaluated (muscle cramping/pain: PLA 0.07%, Cr 0.52%, p = 0.085; GI issues: PLA 4.05%, Cr 5.51%, p = 0.820). Additionally, there was no significant multivariate difference among the 49 side effects evaluated (p = 0.340), no significant difference in the total frequency of side effects reported among participants (PLA 4.21%, Cr 4.60%, p = 0.828), and no significant differences in any of the other side effect evaluated that included markers of renal function and health. The percentage prevalence of side effects was small, with differences between groups generally within ± 0.5%. Analysis of 28.4 million AERs revealed that the mention of Cr was rare (0.00072%), 46.3% of CAERS had no Cr in the products listed, and 63% of AERs with Cr in the product involved the use of other types of Cr or ingestion with other supplements or drugs. The overall sentiment analysis was neutral about perceptions of Cr, although those with strong perceptions about Cr were slightly more negative.Conclusion Results demonstrate that Cr supplementation does not increase the prevalence or frequency of side effects when compared to participants ingesting PLA. Therefore, claims that Cr supplementation increases the risk of side effects are unfounded.

AI snapshot

Written from the paper’s full text.

TL;DR

This comprehensive analysis found that creatine supplementation did not increase the prevalence or frequency of reported side effects compared with placebo across 685 clinical trials, worldwide adverse event reports, and social media sentiment. The authors conclude that claims linking creatine supplementation to increased side-effect risk are unfounded.

Key findings

  • Side effects were reported in 13.2% of placebo studies versus 13.7% of creatine studies (p = 0.776); among participants, 4.21% in placebo groups versus 4.60% in creatine groups reported side effects (p = 0.828).
  • Study-level prevalence was higher for gastrointestinal issues (PLA 4.3%, Cr 4.9%, p < 0.001) and muscle cramping/pain (PLA 0.9%, Cr 2.9%, p = 0.008), but participant-level frequencies were not significantly different (GI: PLA 4.05%, Cr 5.51%, p = 0.820; muscle cramping/pain: PLA 0.07%, Cr 0.52%, p = 0.085).
  • Among 28.4 million adverse event reports, only 203 mentioned creatine with creatine actually in the product (0.00072%); in the US CAERS database, 46.3% of reports listing creatine did not contain creatine when product ingredients were evaluated.
  • Social media sentiment was overall neutral or slightly positive on YouTube (average positive minus negative = 0.0711) and neutral on Twitter/X (0.0098), though strong negative sentiment was more prevalent than strong positive sentiment on Twitter/X (2.09% vs 0.69%).

Methods

  • Comprehensive PubMed review incorporating PRISMA elements; 685 human clinical trials on creatine supplementation were analyzed, with 95% using creatine monohydrate at an average dose of 0.166 [0.159, 0.173] g/kg/d (about 12.5 g/d) for 64.7 [52.0, 77.3] days.
  • Adverse event reports were assessed from the US CAERS, Canadian Vigilance, Australian TGA, European database, and SIDER 4.1; product ingredients were verified to determine whether creatine was actually present.
  • Social media sentiment analysis used Mozdeh/SentiStrength on 129,782 YouTube comments and 657,039 matched Twitter/X tweets; statistical analyses included chi-squared tests, ANOVA, and multivariate/univariate general linear models.

Limitations

  • Stated: the analysis is limited to information provided in publications; some studies lacked full dosage, demographic, or side-effect details; some studies only mentioned side effects from creatine users, which could overinflate creatine-related frequencies; AERs lack detail to assess causality; and social media analysis was limited by Twitter/X API restrictions, irrelevant matches, and coverage of only YouTube and Twitter/X.
  • Evident from the text: the study is an aggregate analysis of existing trials, AERs, and social media posts, so it cannot establish causality between creatine and any individual side effect; AER and sentiment data are not clinical outcomes and may be influenced by reporting or perception biases.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1080/15502783.2025.2488937

Cites

110 of 110 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Claims the paper makes

24 of 58 cited sources checked · 12 supported · 0 flagged · accuracy not yet measured

  • Premisecitation

    The most effective and clinically assessed source of creatine for dietary supplements is creatine monohydrate.

    “The most effective and clinically assessed source of creatine for dietary supplements is creatine monohydrate (CrM) [2].”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [2] Kreider RB, Jager R, Purpura M. Bioavailability, efficacy, safety, and regulatory status of creatine and related compounds: a critical review. Nutrients. 2022; 14(5): 1035. doi: 10.3390/nu14051035 35268011 PMC8912867 source
  • Findingown data

    When the total number of participants in these studies was evaluated, there was no significant difference for GI issues (placebo 4.05%, creatine 5.51%, p = 0.820).

    “GI issues: PLA 4.05%, Cr 5.51%, p = 0.820”
    Quote in the paperSubstantial claim
  • Findingown data

    Nearly all studies (648/685 or 95%) were conducted using creatine monohydrate as the source of creatine.

    “Nearly all studies (648/685 or 95%) were conducted using CrM as the source of creatine.”
    Quote in the paperNot a substantial claim
  • Findingown data

    There was no significant multivariate difference among the 49 side effects evaluated (p = 0.340).

    “no significant multivariate difference among the 49 side effects evaluated (p = 0.340)”
    Quote in the paperSubstantial claim
  • Findingown data

    The majority of YouTube comments on creatine exhibit no strong sentiment.

    “The majority of comments exhibit no strong sentiment”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim. 31
  • May combine two claims. 42
  • Classified as probably not a substantial claim.

    Study design and conductcitation

    The adverse event report databases were searched for creatine in dietary supplements or products following accepted protocols.

    “These databases were searched for “creatine’ in dietary supplements or products following accepted protocols [61,62].”
    Quote in the paperSubstantial claim1 of 2 sources checked
    • cites [61] Timbo BB, Chirtel SJ, Ihrie J, et al. Dietary supplement adverse event report data from the FDA center for food safety and applied nutrition adverse event reporting system (CAERS), 2004–2013. Ann Pharmacother. 2018; 52(5): 431– 438. 29171279 source
    • cites [62] Ng JY, Munford V, Thakar H. Web-based online resources about adverse interactions or side effects associated with complementary and alternative medicine: a systematic review, summarization and quality assessment. BMC Med Inform Decis Mak. 2020; 20(1). PMC7653751 33167980 source

      The Results section, under “Summaries of included online resources” (page unavailable), describes databases containing information on adverse effects and supplements. The Methods sections describe selecting and assessing those resources, not searching adverse-event report databases for creatine. Searches of our copy for “creatine” and “accepted protocols” found no passage documenting the claimed search. (LLM, conf=0.76)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductcitation

    This review incorporated elements of the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines.

    “This review incorporated elements of the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines [57].”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [57] Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021. PMC8005924 33782057 source
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    Anecdotally reported side effects and claims that creatine monohydrate is not as effective as other forms of creatine continue to permeate the Internet.

    “Nevertheless, anecdotally reported side effects and claims that CrM is not as effective as other “forms” of creatine continue to permeate the Internet [2,50].”
    Quote in the paperNot a substantial claim2 of 2 sources checked
    • cites [2] Kreider RB, Jager R, Purpura M. Bioavailability, efficacy, safety, and regulatory status of creatine and related compounds: a critical review. Nutrients. 2022; 14(5): 1035. doi: 10.3390/nu14051035 35268011 PMC8912867 source

      Section 8 (Creatine Monohydrate; page unavailable) describes anecdotal side-effect claims and says companies have used such claims in marketing. The Introduction (page unavailable) describes marketing claims that other forms are more effective than CrM. The Methods say the authors reviewed company websites, but the cited passages do not establish that these claims continue to permeate the Internet. (LLM, conf=0.79)

      Experimental — accuracy not yet measured
    • cites [50] Jager R, Purpura M, Shao A, et al. Analysis of the efficacy, safety, and regulatory status of novel forms of creatine. Amino Acids. 2011 May; 40(5): 1369– 1383. 21424716 PMC3080578 source

      The Summary (page not provided) reports marketing claims that newer forms of creatine are more effective and have fewer side effects than creatine monohydrate. It does not say that anecdotal side-effect reports or these claims continue to permeate the Internet. (LLM, conf=0.84)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Premisecitation

    Professional organizations, athletic governing bodies, and the Office of Dietary Supplements at the National Institutes of Health recognize creatine monohydrate as a safe, effective, and legal nutritional strategy to enhance performance and training adaptations.

    “Based on this evidence, professional organizations [12,16–18], athletic governing bodies [19]; and the Office of Dietary Supplements at the National Institutes of Health [20] recognize CrM as a safe, effective, and legal nutritional strategy to enhance performance and training adaptations.”
    Quote in the paperNot a substantial claim3 of 6 sources checked
    • cites [12] Kreider RB, Kalman DS, Antonio J, et al. International society of sports nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine. J Int Soc Sports Nutr. 2017; 14: 18. 28615996 PMC5469049 source
    • cites [16] Buford TW, Kreider RB, Stout JR, et al. International society of sports nutrition position stand: creatine supplementation and exercise. J Int Soc Sports Nutr. 2007 Aug 30; 4(1): 6. doi: 10.1186/1550-2783-4-6 17908288 PMC2048496 source
    • cites [17] Rodriguez NR, DiMarco NM, Langley S, et al. Position of the American dietetic association, dietitians of Canada, and the American college of sports medicine: nutrition and athletic performance. J Am Diet Assoc. 2009 Mar; 109(3): 509– 527. 19278045 source
    • cites [18] Thomas DT, Erdman KA, Burke LM. Position of the academy of nutrition and dietetics, dietitians of Canada, and the American college of sports medicine: nutrition and athletic performance. J Acad Nutr Diet. 2016 Mar; 116(3): 501– 528. doi: 10.1016/j.jand.2015.12.006 26920240 source
    • cites [19] Maughan RJ, Burke LM, Dvorak J, et al. IOC consensus statement: dietary supplements and the high-performance athlete. Int J Sport Nutr Exerc Metab. 2018; 28(2): 104– 125. doi: 10.1123/ijsnem.2018-0020 29589768 source

      The IOC consensus statement’s Overview reports that creatine improves repeated high-intensity performance and training adaptations, and notes no negative health effects with appropriate long-term use. Our copy does not explicitly establish the claim that creatine monohydrate is legal in sport; it also cautions that supplements can contain prohibited substances. This citation is attached to the athletic-governing-body portion of the sentence, not the claims about other organizations or the NIH. (LLM, conf=0.84)

      Experimental — accuracy not yet measured
    • cites [20] National Institutes of Health. Office of dietary supplements, dietary supplement fact sheets: dietary supplements for exercise and athletic performance. U.S. Department of Health and Human Services; 2021 [ cited 2021 Mar 29]. Available from: https://ods.od.nih.gov/factsheets/ExerciseAndAthleticPerformance-HealthProfessional/

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    To date, hundreds of clinical trials have been conducted in humans on healthy and medically managed populations with no adverse events reported and relatively few, if any, side effects noted.

    “To date, hundreds of clinical trials have been conducted in humans on healthy and medically managed populations with no adverse events reported and relatively few, if any, side effects noted [2,4,12,50].”
    Quote in the paperSubstantial claim4 of 4 sources checked
    • cites [2] Kreider RB, Jager R, Purpura M. Bioavailability, efficacy, safety, and regulatory status of creatine and related compounds: a critical review. Nutrients. 2022; 14(5): 1035. doi: 10.3390/nu14051035 35268011 PMC8912867 source

      Section 8 (Creatine Monohydrate; page not provided) describes numerous controlled clinical trials, studies in healthy and clinical populations, and no reported side effects other than desired weight gain. It does not establish the specific count of hundreds of trials or explicitly say that no adverse events were reported. Its safety conclusion concerns creatine monohydrate, not all forms of creatine. (LLM, conf=0.85)

      Experimental — accuracy not yet measured
    • cites [4] Kreider RB, Stout JR. Creatine in health and disease. Nutrients. 2021; 13(2): 447. doi: 10.3390/nu13020447 33572884 PMC7910963 source

      The Introduction and §4 (General Health Benefits; page unavailable) describe creatine research in healthy people and investigations of its therapeutic use in people with medical conditions. They do not establish that hundreds of human clinical trials reported no adverse events or relatively few side effects. (LLM, conf=0.78)

      Experimental — accuracy not yet measured
    • cites [12] Kreider RB, Kalman DS, Antonio J, et al. International society of sports nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine. J Int Soc Sports Nutr. 2017; 14: 18. 28615996 PMC5469049 source

      The Safety section reports extensive study in healthy and diseased populations, with no significant adverse health risks and weight gain as the only consistently reported side effect. It says over 1,000 studies were conducted, but does not establish that hundreds were human clinical trials; it also says creatine was rarely mentioned in adverse-event reports, rather than that no adverse events were reported. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
    • cites [50] Jager R, Purpura M, Shao A, et al. Analysis of the efficacy, safety, and regulatory status of novel forms of creatine. Amino Acids. 2011 May; 40(5): 1369– 1383. 21424716 PMC3080578 source

      The Creatine monohydrate section reports human safety studies and says the only clinically significant side effect reported was weight gain; the Summary says no medically significant side effects have been reported from creatine monohydrate supplementation. The paper does not establish that hundreds of clinical trials were conducted or that no adverse events of any kind were reported. Its safety conclusion also does not extend to newer forms of creatine. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Premisecitation

    Creatine monohydrate is considered Generally Recognized as Safe (GRAS) by the FDA in the United States and is the only form of creatine approved for sale in the United States, Canada, Europe, Australia, Japan, the Republic of Korea, and China.

    “CrM is considered Generally Recognized as Safe (GRAS) by the Food and Drug Administration (FDA) in the United States [51] and is the only form of creatine approved for sale in the United States, Canada, Europe, Australia, Japan, the Republic of Korea, and China [2].”
    Quote in the paperNot a substantial claim1 of 2 sources checked
    • cites [51] GRN No. 931 Creatine Monohydrate. U.S. Department of health and human services. U.S. Food and Drug Administration; 2020.

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites [2] Kreider RB, Jager R, Purpura M. Bioavailability, efficacy, safety, and regulatory status of creatine and related compounds: a critical review. Nutrients. 2022; 14(5): 1035. doi: 10.3390/nu14051035 35268011 PMC8912867 source

      Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

      Experimental — accuracy not yet measured
  • May combine two claims.

    Premisecitation

    A few case study reports appeared in the literature suggesting adverse events despite other mitigating factors unrelated to creatine supplementation, which subsequently have been debunked.

    “A few case study reports also appeared in the literature suggesting adverse events despite other mitigating factors unrelated to creatine supplementation [52–54] which subsequently have been debunked [15,55,56].”
    Quote in the paperNot a substantial claim4 of 6 sources checked
    • cites [52] Pritchard NR, Kalra PA. Renal dysfunction accompanying oral creatine supplements. Lancet. 1998 Apr 25; 351(9111): 1252– 1253. doi: 10.1016/S0140-6736(05)79319-3 9643752 source
    • cites [53] Révai T, Sápi Z, Benedek S, et al. Severe nephrotic syndrome in a young man taking anabolic steroid and creatine long term. Orv Hetil. 2003 Dec 7; 144(49): 2425– 2427. 14725210
    • cites [54] Robles EL, Pache KM, Gluck JS. Acute compartment syndrome of the leg caused by cocaine use, creatine supplementation and vigorous exercise. J Surg Case Rep. 2022 Nov; 2022(11): rjac502. doi: 10.1093/jscr/rjac502 36776243 PMC9907039 source
    • cites [15] Antonio J, Brown AF, Candow DG, et al. Part II. Common questions and misconceptions about creatine supplementation: what does the scientific evidence really show? J Int Soc Sports Nutr. 2025 Dec; 22(1): 2441760. doi: 10.1080/15502783.2024.2441760 39720835 PMC11703406 source

      The supplied References passages do not address the reported cases. A search of the paper’s sections on adverse effects found discussion of unsupported claims about male fertility and blood pressure, but no passage identifying adverse-event case reports, their unrelated mitigating factors, or their subsequent debunking. Searches included “case reports,” “adverse events,” and “confounding factors.” (LLM, conf=0.70)

      Experimental — accuracy not yet measured
    • cites [55] Rawson ES, Clarkson PM, Tarnopolsky MA. Perspectives on exertional Rhabdomyolysis. Sports Med. 2017; 47(Suppl 1): 33– 49. PMC5371628 28332112 source
    • cites [56] Antonio J, Candow DG, Forbes SC, et al. Common questions and misconceptions about creatine supplementation: what does the scientific evidence really show? J Int Soc Sports Nutr. 2021; 18(1): 13. doi: 10.1186/s12970-021-00412-w 33557850 PMC7871530 source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    The 2017 ISSN position noted that given the known benefits and safety profile of creatine supplementation, government legislatures and sports organizations who restrict and/or discourage the use of creatine may be placing athletes at greater risk.

    “The 2017 position noted that given the known benefits and safety profile of creatine supplementation, government legislatures and sports organizations who restrict and/or discourage the use of creatine may be placing athletes at greater risk [12].”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [12] Kreider RB, Kalman DS, Antonio J, et al. International society of sports nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine. J Int Soc Sports Nutr. 2017; 14: 18. 28615996 PMC5469049 source
  • May combine two claims.

    Premisecitation

    Present findings are consistent with other safety studies on creatine supplementation and the long-term study conducted in Parkinson's patients.

    “They are also consistent with other safety studies on creatine supplementation [50,80,84–87,89,91–109] and the long-term study conducted in Parkinson’s patients [74].”
    Quote in the paperNot a substantial claim1 of 10 sources checked
    • cites [50] Jager R, Purpura M, Shao A, et al. Analysis of the efficacy, safety, and regulatory status of novel forms of creatine. Amino Acids. 2011 May; 40(5): 1369– 1383. 21424716 PMC3080578 source
    • cites [80] Volek JS, Mazzetti SA, Farquhar WB, et al. Physiological responses to short-term exercise in the heat after creatine loading. Med Sci Sports Exerc. 2001 Jul; 33(7): 1101– 1108. 11445756 source
    • cites [84] Greenwood M, Farris J, Kreider R, et al. Creatine supplementation patterns and perceived effects in select division I collegiate athletes. Clin J Sport Med. 2000 Jul; 10(3): 191– 194. 10959929 source
    • cites [85] Greenwood M, Kreider RB, Greenwood L, et al. Cramping and injury incidence in collegiate football players are reduced by creatine supplementation. J Athl Train. 2003; 38(3): 216– 219. 14608430 PMC233174 source
    • cites [86] Greenwood M, Kreider RB, Melton C, et al. Creatine supplementation during college football training does not increase the incidence of cramping or injury. Mol Cell Biochem. 2003 Feb; 244(1–2): 83– 88. 12701814 source
    • cites [87] Kreider RB, Melton C, Rasmussen CJ, et al. Long-term creatine supplementation does not significantly affect clinical markers of health in athletes. Mol Cell Biochem. 2003 Feb; 244(1–2): 95– 104. 12701816 source
    • cites [89] Vandenberghe K, Goris M, Van Hecke P, et al. Long-term creatine intake is beneficial to muscle performance during resistance training. J Appl Physiol (1985). 1997; 83(6): 2055– 2063. doi: 10.1152/jappl.1997.83.6.2055 9390981 source
    • cites [91] Hile AM, Anderson JM, Fiala KA, et al. Creatine supplementation and anterior compartment pressure during exercise in the heat in dehydrated men. J Athl Train. 2006 Jan-Mar; 41(1): 30– 35. 16619092 PMC1421498
    • cites [92] Watson G, Casa DJ, Fiala KA, et al. Creatine use and exercise heat tolerance in dehydrated men. J Athl Train. 2006 Jan-Mar; 41(1): 18– 29. 16619091 PMC1421496
    • cites [93] Easton C, Turner S, Pitsiladis YP. Creatine and glycerol hyperhydration in trained subjects before exercise in the heat. Int J Sport Nutr Exerc Metab. 2007 Feb; 17(1): 70– 91. 17460334 source
  • May combine two claims.

    Premisecitation

    Most studies show that creatine supplementation can benefit healthy active populations as they age and provide therapeutic benefits in some clinical populations.

    “Most studies show that creatine supplementation can benefit healthy active populations as they age and provide therapeutic benefits in some clinical populations [2,4].”
    Quote in the paperNot a substantial claim2 of 2 sources checked
    • cites [2] Kreider RB, Jager R, Purpura M. Bioavailability, efficacy, safety, and regulatory status of creatine and related compounds: a critical review. Nutrients. 2022; 14(5): 1035. doi: 10.3390/nu14051035 35268011 PMC8912867 source
    • cites [4] Kreider RB, Stout JR. Creatine in health and disease. Nutrients. 2021; 13(2): 447. doi: 10.3390/nu13020447 33572884 PMC7910963 source
  • Classified as probably not a substantial claim. May combine two claims.

    Premisecitation

    The ISSN concluded in its 2007 and 2017 position stands that CrM was safe and effective for all ages and that additional research should evaluate potential therapeutic benefits of creatine in clinical populations.

    “Consequently, the ISSN concluded in its 2007 [16] and the 2017 position stands [12] that CrM was safe and effective for all ages and that additional research should evaluate the potential therapeutic benefits of creatin in clinical populations that may benefit.”
    Quote in the paperSubstantial claim2 of 2 sources checked
    • cites [16] Buford TW, Kreider RB, Stout JR, et al. International society of sports nutrition position stand: creatine supplementation and exercise. J Int Soc Sports Nutr. 2007 Aug 30; 4(1): 6. doi: 10.1186/1550-2783-4-6 17908288 PMC2048496 source

      The Conclusion calls creatine monohydrate safe and effective within established guidelines, and the Medical Safety section says more research is needed to determine its clinical utility. But the Children and Adolescents section limits the ISSN’s recommendation for younger athletes to specific conditions, so the 2007 stand does not establish safety and effectiveness for all ages without qualification. This verdict concerns the cited 2007 stand, not the separately cited 2017 stand; page numbers are unavailable in our copy. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
    • cites [12] Kreider RB, Kalman DS, Antonio J, et al. International society of sports nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine. J Int Soc Sports Nutr. 2017; 14: 18. 28615996 PMC5469049 source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Much of the misinformation about creatine comes from companies and influencers who promote different types of creatine as more effective than CrM with fewer side effects.

    “Much of the misinformation about creatine comes from companies and influencers who are promoting different types of creatine as more effective than CrM with fewer “side effects” [2].”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [2] Kreider RB, Jager R, Purpura M. Bioavailability, efficacy, safety, and regulatory status of creatine and related compounds: a critical review. Nutrients. 2022; 14(5): 1035. doi: 10.3390/nu14051035 35268011 PMC8912867 source

      The Introduction (section 1; page unavailable) says companies market alternative forms of creatine as more effective than CrM and describes marketing claims that they have fewer side effects, despite little or no supporting evidence. The paper does not identify influencers as promoters or establish that these claims account for much of the misinformation about creatine. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Findingown data

    Side effects were reported in 13.2% of studies in the placebo groups and 13.7% of studies in the creatine-supplemented groups, with no significant difference between groups (p = 0.776).

    “Side effects were reported in 13.2% of studies in the PLA groups and 13.7% of studies in the Cr-supplemented groups, with no significant differences observed between the groups (p = 0.776).”
    • Also stated in: § Prevalence of studies reporting side effects · plain
      “In the placebo group, 86/652 studies (13.2%) reported side effects, while 94/685 (13.7%) reported side effects in creatine-supplemented (p = 0.776).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    The time series scanning revealed a continuous increase in YouTube comments with important peaks in July 2021, March 2022, August 2023, and September 2024.

    “The time series scanning revealed a continuous increase in YouTube comments with important peaks in July 2021, March 2022, August 2023, and September 2024 (Figure 2(d)).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    Studies included sample sizes up to 874 participants and participants up to 77 years old in studies lasting up to 14 years.

    “This included studies with sample sizes up to 874 participants and participants up to 77 years old in studies lasting up to 14 years.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    No other significant differences were observed in the number of studies reporting the remaining 33 side effects between the placebo and creatine-supplemented groups, with the difference in prevalence typically ±0.4%.

    “No other significant differences were observed in the number of studies reporting the remaining 33 side effects between the placebo and creatine-supplemented groups, with the difference in prevalence reported typically ±0.4%.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    No significant differences were found on average sentiment; there was a neutral sentiment on creatine if considering mean values of the analyzed population (mean positive - mean negative = 0.0098).

    “No significant differences were found on average sentiment; therefore, there was a neutral sentiment on creatine if we consider the mean values of the analyzed population (mean positive – mean negative = 0.0098).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    Among CAERS reports that contained creatine as an ingredient, 37% listed CrM as the only product the individual was consuming, and 63% contained other nutrients consumed with CrM.

    “Among the CAERS that contained creatine as an ingredient, 37% listed CrM as the only product the individual was consuming, and 63% contained other nutrients consumed with CrM.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Findingown data

    We identified over 400 scholarly reviews and 100 meta-analyses about creatine supplementation.

    “Additionally, we identified over 400 scholarly reviews and 100 meta-analyses about creatine supplementation.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    The percentage prevalence in the frequency of reported side effects was very small between creatine and placebos overall, and when categorized by sex, age, and comparing healthy and clinical populations.

    “the percentage prevalence in the frequency of reported side effects was very small between those taking creatine and placebos overall, as well as when categorized by sex (Table S7), age (Table S8), and comparing healthy and clinical populations (Table S9).”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingown data

    For "HCl," significant associations were found with words like "stomach," "better," "bloating," "superior," "expensive," "cost" and "soluble."

    “In the case of “HCl,” significant associations were found with words like “stomach,” “better,” “bloating,” “superior,” “expensive,” “cost” and “soluble.””
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingown data

    A total of 129,782 comments were collected from YouTube videos published between April 2011 and February 2025 that contained the term "creatine" in their title or description.

    “A total of 129,782 comments were collected from YouTube videos published between April 2011 and February 2025 that contained the term “creatine” in their title or description.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    No significant differences were observed when comparing the frequency of side effects among healthy and clinical populations, even though clinical populations generally consumed a greater amount of creatine for longer periods.

    “No significant differences were observed when comparing the frequency of side effects among healthy and clinical populations, even though clinical populations generally consumed a greater amount of creatine for longer periods of time.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingown data

    In the univariate analysis, 13,452 participants ingested placebos and 12,839 consumed creatine supplements (p = 0.411).

    “Univariate analysis revealed that 13,452 participants ingested placebos, while 12,839 consumed creatine supplements (p = 0.411).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    4.21% of placebo participants reported a side effect, while 4.60% of creatine participants reported side effects (p = 0.828).

    “Of these, 4.21% of participants ingesting placebos reported having a side effect, while 4.60% of participants consuming creatine supplements reported side effects (p = 0.828).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    The percentage prevalence of side effects was small, with differences between groups generally within ±0.5%.

    “The percentage prevalence of side effects was small, with differences between groups generally within ± 0.5%.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    The average study had 19.7 participants who were 30.1 years old, 75.5 kg body mass, ingested supplements for 64.7 days, and consumed an average of 0.166 g/kg/d of supplements or 480 g total (about 12.5 g/d).

    “Overall, the average study had 19.7 [17.4, 21.9] participants who were 30.1 [29.3, 30.9] years, 75.5 [74.9, 76.2] kg body mass, ingested the supplements for 64.7 [52.0, 77.3] days, and consumed an average of 0.166 [0.159, 0.173] g/kg/d of supplements or 480 [388, 623] g total of supplements (about 12.5 g/d).”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingown data

    No significant differences were observed between those taking placebo and creatine supplements among demographic-related variables.

    “No significant differences were observed between those taking PLA and Cr supplements among demographic-related variables.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    Of CAERS reports with creatine, only 15.8% involved ingestion of CrM with other nutrients, 47.3% involved other types of creatine, and 43.6% involved ingesting creatine with nutritional products or drugs.

    “Of these, only 15.8% involved ingestion of CrM with other nutrients, 47.3% involved other types of creatine, and 43.6% involved ingesting creatine with nutritional products or drugs”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    As sentiment strength increases, the number of YouTube comments decreases, with positive comments remaining more prevalent.

    “As sentiment strength increases, the number of comments decreases, with positive comments remaining more prevalent.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    YouTube comments containing the word "monohydrate" remain generally neutral despite having a higher percentage of comments with weak and moderate positive sentiments (average positive - average negative = 0.1033).

    “comments containing the word “monohydrate” remain generally neutral despite having a higher percentage of comments with weak and moderate positive sentiments (average positive – average negative = 0.1033)”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    Overall, positive YouTube comments on creatine outnumber negative ones, though neutral comments show a slightly higher proportion of negativity.

    “Overall, positive comments (blue) outnumber negative ones (orange), though neutral comments show a slightly higher proportion of negativity (Figure 2(a)).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    Relative creatine doses were higher in children and adolescents (0.280 g/kg/d) and taken for longer periods (324.1 days) than older cohorts.

    “Additionally, relative creatine doses were higher in children and adolescents (0.280 [0.184, 0.375] g/kg/d) and taken for longer periods of time (324.1 [23.6, 624.5] d) than older cohorts.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    Our literature search revealed that over 680 clinical trials have been conducted in humans on creatine supplementation (95% as creatine monohydrate) on over 26,000 participants.

    “Our literature search revealed that over 680 clinical trials have been conducted in humans on creatine supplementation (95% as creatine monohydrate) on over 26,000 participants.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Findingnone given

    Similar findings were seen when looking at the products associated with AERs from other databases.

    “Similar findings were seen when looking at the products associated with AERs from other databases.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    Although some significant differences were noted among sex and age categories, the percent differences in frequency of side effects between placebo and creatine were in most cases less than ±0.5% and in some cases higher in those consuming placebos.

    “Although some significant differences were noted among sex and age categories, the percent differences in the frequency of side effects between participants consuming placebos and creatine were, in most cases, less than ±0.5% and, in some cases, higher in those consuming placebos.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Findingown data

    Both "HCl" and "monohydrate" were highly associated with each other, but the match percentage was lower for monohydrate.

    “Both “HCl” and “monohydrate” were highly associated with each other, but the match percentage was lower for the latter.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    The AER analysis revealed evidence of inaccurate reporting and linking creatine to AERs.

    “It also revealed evidence of inaccurate reporting and linking creatine to AERs.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingown data

    Sentiment analysis suggests that a small percentage of the public may have a stronger negative view about creatine supplementation.

    “while the sentiment analysis suggests that a small percentage of the public may have a stronger negative view about creatine supplementation”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: Social media sentiment analysis accurately reflects public perceptions about creatine supplementation.
  • Classified as probably not a substantial claim.

    Findingnone given

    This includes assessment of side effect symptomology and markers of health and renal function.

    “This includes assessment of side effect symptomology and markers of health and renal function.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingnone given

    The number of studies and frequency of participants experiencing other side effects were very low and not significantly different than placebos (±0.5%).

    “Additionally, the number of studies and frequency of participants experiencing other side effects were very low and not significantly different than placebos (±0.5%).”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Findingnone given

    Most identified reviews conclude that creatine supplementation can provide some performance and/or clinical benefit, and most meta-analyses report some efficacy.

    “Most of those reviews conclude that creatine supplementation can provide some performance and/or clinical benefit, and most meta-analyses report some efficacy.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Findingnone given

    A large percentage of AERs mention creatine but were not actually in the products listed.

    “given a large percentage of AERs mention creatine but were not actually in the products listed”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductcitation

    The accuracy of the sentiment analysis method has been published previously.

    “The accuracy of this method has been published previously [69].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [69] Thelwall M, Buckley K, Paltoglou G. Sentiment strength detection for the social web. J Am Soc Inf Sci Technol. 2012; 63(1): 163– 173. source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Sentiment analysis has been shown to be an effective strategy for social web text analytics.

    “This has been shown to be an effective strategy for social web text analytics [66] with large and variate applications [67,68].”
    Quote in the paperNot a substantial claim0 of 3 sources checked
    • cites [66] Kumar A, Garg G. Systematic literature review on context-based sentiment analysis in social multimedia. Multimedia Tools Appl. 2019; 79(21–22): 15349– 15380. doi: 10.1007/s11042-019-7346-5 source
    • cites [67] Chenworth M, Perrone J, Love JS, et al. Methadone and suboxone® mentions on twitter: thematic and sentiment analysis. Clin Toxicol. 2021: 1– 14. PMC9177078 33821724 source
    • cites [68] Saha G, Roy S, Maji P. Sentiment analysis of twitter data related to COVID-19. Impac AI data sci in response to coronavirus pandemic. Algoritms Intell Syst 2021. 169– 191.

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Interpretationreasoning

    When people comment on HCl, they generally also mention monohydrate (37%), whereas the opposite occurs less frequently (17%).

    “This might indicate that when people comment on HCl, they generally also mention monohydrate (37%), whereas the opposite occurs less frequently (17%).”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Study design and conductnone given

    In some cases, full details about study dosages, demographics of participants, and side effects were not provided.

    “In some cases, full details about study dosages, demographics of participants, and side effects were not provided.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim.

    Study design and conductnone given

    This analysis is limited to the information provided in publications about the safety of creatine supplementation.

    “This analysis is limited to the information provided in publications about the safety of creatine supplementation.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Big data text analysis enables the use of manual judgments to identify parameters for disambiguating instances of automatically identified clues.

    “it must be noted that big data text analysis enables us to use manual judgments to identify parameters for disambiguating instances of automatically identified clues [119].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [119] Wiebe J, Wilson T, Bruce R, et al. Learning subjective language. Comput Linguistics. 2004; 30(3): 277– 308. doi: 10.1162/0891201041850885 source
  • Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing), S4 (based).

    Interpretationreasoning

    This type of misinformation only confused the public.

    “This type of misinformation only confused the public.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    Present findings are similar to results reported in the authors' long-term creatine safety study on American football players, where up to 21 months of creatine supplementation (5-10 g/d) in division I American football players did not significantly affect markers of health or renal function.

    “Present findings are similar to results reported in our long-term creatine safety study on American football players [86,87], where we showed that up to 21 months of creatine supplementation (5–10 g/d) in division I American football players did not significantly affect markers of health or renal function [87]”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites [86] Greenwood M, Kreider RB, Melton C, et al. Creatine supplementation during college football training does not increase the incidence of cramping or injury. Mol Cell Biochem. 2003 Feb; 244(1–2): 83– 88. 12701814 source
    • cites [87] Kreider RB, Melton C, Rasmussen CJ, et al. Long-term creatine supplementation does not significantly affect clinical markers of health in athletes. Mol Cell Biochem. 2003 Feb; 244(1–2): 95– 104. 12701816 source
  • May combine two claims.

    Interpretationown data

    In some cases, AERs report symptoms creatine studies never observed in any clinical trial or are unrelated to the known effects of creatine supplementation.

    “and in some cases report symptoms creatine studies never observed in any clinical trial or are unrelated to the known effects of creatine supplementation.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: AERs provide a valid indication of the prevalence of adverse events associated with creatine supplementation.
  • May combine two claims.

    Interpretationown data

    Collectively, these findings indicate that creatine supplementation is well tolerated and not associated with a disproportionate increase in any purported side effect or clinical marker of health.

    “Collectively, these findings indicate that creatine supplementation is well tolerated and not associated with a disproportion increase in any purported side effect or clinical marker of health.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Study design and conductnone given

    The Twitter (X) API has time and size restrictions that affect the process of data gathering.

    “First, the Twitter (X) API has time and size restrictions that affect the process of data gathering.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationreasoning

    While individuals taking creatine supplements may experience GI issues and muscle cramping/pain, the incidence is low and not different from those taking placebos.

    “This means that while individuals taking creatine supplements may experience GI issues and muscle cramping/pain, the incidence is low and not different from those taking placebos.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    Other studies found that creatine supplementation did not increase the incidence of musculoskeletal injuries, dehydration, muscle cramping, gastrointestinal issues, renal dysfunction, or long-term detrimental effects.

    “Other studies directly assessed the merit of anecdotal reports of side effects and found that creatine supplementation did not increase the incidence of musculoskeletal injuries [84–87], dehydration [85,86,91–96], muscle cramping [80,85,86,92,97], gastrointestinal issues [84–87], promote renal dysfunction [87,89,98–107], or have long-term detrimental effects [50,87,106,108,109].”
    Quote in the paperSubstantial claim0 of 10 sources checked
    • cites [84] Greenwood M, Farris J, Kreider R, et al. Creatine supplementation patterns and perceived effects in select division I collegiate athletes. Clin J Sport Med. 2000 Jul; 10(3): 191– 194. 10959929 source
    • cites [85] Greenwood M, Kreider RB, Greenwood L, et al. Cramping and injury incidence in collegiate football players are reduced by creatine supplementation. J Athl Train. 2003; 38(3): 216– 219. 14608430 PMC233174 source
    • cites [86] Greenwood M, Kreider RB, Melton C, et al. Creatine supplementation during college football training does not increase the incidence of cramping or injury. Mol Cell Biochem. 2003 Feb; 244(1–2): 83– 88. 12701814 source
    • cites [87] Kreider RB, Melton C, Rasmussen CJ, et al. Long-term creatine supplementation does not significantly affect clinical markers of health in athletes. Mol Cell Biochem. 2003 Feb; 244(1–2): 95– 104. 12701816 source
    • cites [91] Hile AM, Anderson JM, Fiala KA, et al. Creatine supplementation and anterior compartment pressure during exercise in the heat in dehydrated men. J Athl Train. 2006 Jan-Mar; 41(1): 30– 35. 16619092 PMC1421498
    • cites [92] Watson G, Casa DJ, Fiala KA, et al. Creatine use and exercise heat tolerance in dehydrated men. J Athl Train. 2006 Jan-Mar; 41(1): 18– 29. 16619091 PMC1421496
    • cites [93] Easton C, Turner S, Pitsiladis YP. Creatine and glycerol hyperhydration in trained subjects before exercise in the heat. Int J Sport Nutr Exerc Metab. 2007 Feb; 17(1): 70– 91. 17460334 source
    • cites [94] Dalbo VJ, Roberts MD, Stout JR, et al. Putting to rest the myth of creatine supplementation leading to muscle cramps and dehydration. Br J Sports Med. 2008; 42(7): 567– 573. 18184753 source
    • cites [95] Lopez RM, Casa DJ, McDermott BP, et al. Does creatine supplementation hinder exercise heat tolerance or hydration status? A systematic review with meta-analyses. J Athl Train. 2009 Mar-Apr; 44(2): 215– 223. 19295968 PMC2657025 source
    • cites [96] Rosene JM, Matthews TD, McBride KJ, et al. The effects of creatine supplementation on thermoregulation and isokinetic muscular performance following acute (3-day) supplementation. J Sports Med Phys Fitness. 2015; 55(12): 1488– 1496. 25781214
  • May combine two claims.

    Interpretationown data

    While more clinical trials reported GI issues and muscle cramping/pain in creatine users versus non-users, the percentage incidence was small, and the total number of participants experiencing these issues in all studies was not significantly different between those taking creatine and placebos.

    “These findings indicate that while more clinical trials reported these issues in creatine users versus non-users, the percentage incidence was small, and the total number of participants experiencing these issues in all studies was not significantly different between those taking creatine and placebos.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Study design and conductnone given

    The query strategy normally matches many irrelevant YouTube comments and tweets.

    “Also, the query strategy normally matches many irrelevant YouTube comments and tweets as well.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Study design and conductnone given

    AERs do not provide enough detail to assess causality and may not be attributed to creatine supplementation.

    “Although AERs do not provide enough detail to assess causality and may not be attributed to creatine supplementation”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing), S4 (based).

    Interpretationown data

    These data objectively support the positive impact of bridging the gap between high-level researchers and the general population through social media.

    “these data objectively support the positive impact of bridging the gap between high-level researchers (e.g. Creatine For Health is an initiative that brings together the world’s leading creatine researchers to accelerate awareness of the role of creatine supplementation in health and clinical diseases) and the general population through social media.”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: Social media sentiment analysis accurately reflects public perceptions about creatine supplementation.
  • May combine two claims.

    Interpretationown data

    Given creatine has been taken billions of times since it became a popular dietary supplement in the early 1990s, the lack of AERs reported in worldwide databases is consistent with the lack of side effects observed in clinical trials.

    “Given creatine has been taken billions of times since it became a popular dietary supplement in the early 1990s, the lack of AERs reported in worldwide databases is consistent with the lack of side effects observed in clinical trials.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: Creatine has been taken billions of times since it became a popular dietary supplement in the early 1990s.
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Study design and conductreasoning

    Some studies only mentioned side effects from those taking creatine with no mention of side effects from taking placebos, which would overinflate the frequency reported with creatine supplementation.

    “Some studies only mentioned side effects from those taking creatine with no mention of side effects from taking placebos which would overinflate the frequency reported with creatine supplementation.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Interpretationreasoning

    Some of the side effects reported in AERs appear unrelated to the known effects of creatine supplementation.

    “some of the side effects reported appear unrelated to the known effects of creatine supplementation”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    Full details are not provided in AERs to assess causality.

    “It should also be noted that full details are not provided in AERs to assess causality.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing), S4 (based). May combine two claims.

    Interpretationnone given

    Inaccurate information on the Internet and social media platforms has persisted, confusing the public and healthcare professionals.

    “Yet, inaccurate information on the Internet and social media platforms has persisted, confusing the public and healthcare professionals.”
    Quote in the paperNot a substantial claim
65 of 65
  • The paper relies on this without support.

    Anecdotal reports about side effects of creatine supplementation persist primarily from popular and social media and on the Internet.

    “Nevertheless, anecdotal reports about side effects persist primarily from popular and social media and on the Internet.”
  • The paper relies on this without support.

    Misinformation about creatine safety has created concern among athletes, parents, physicians, medical providers, the elderly, and patient populations who may benefit from creatine monohydrate supplementation.

    “This misinformation has created concern among athletes, parents, physicians, medical providers, the elderly, and patient populations who may benefit from CrM supplementation regarding safety.”
  • The paper relies on this without support.

    Misinformation about creatine safety has prompted some legislative efforts to limit the availability of creatine in dietary supplements to populations who may benefit.

    “It has also prompted some legislative efforts to limit the availability of creatine in dietary supplements to populations who may benefit.”
  • The paper relies on this without support.

    Creatine has been taken billions of times since it became a popular dietary supplement in the early 1990s.

    “Given creatine has been taken billions of times since it became a popular dietary supplement in the early 1990s”
  • The paper relies on this without support.

    AERs provide a valid indication of the prevalence of adverse events associated with creatine supplementation.

    “Additionally, the mention of creatine in worldwide AERs is rare (0.00072%)”
    “It should also be noted that full details are not provided in AERs to assess causality.”
  • The paper relies on this without support.

    Social media sentiment analysis accurately reflects public perceptions about creatine supplementation.

    “While the overall assessment was the public was neutral about their positive and negative perceptions of creatine supplementation”
    “while the sentiment analysis suggests that a small percentage of the public may have a stronger negative view about creatine supplementation”
6 of 6

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • Creatine GI-study prevalence is reported as 4.9% instead of 9.2%

    Major

    Table 2 reports GI issues in 63 of 685 creatine studies, or 9.20%. The abstract calls 4.9% the creatine-group prevalence; approximately 4.9 percentage points is the difference between groups, not the creatine-group rate.

    Reported 4.9 · recomputed 9.19708

  • Total percentage of creatine mentions without creatine is zero despite 142 reports

    Minor

    Table 4 lists 142 such reports among 345 reports mentioning creatine. The total-column percentage should be about 41.16%, not 0.00000%.

    Reported 0 · recomputed 41.15942

  • Discussion overstates placebo GI participant prevalence

    Minor

    The discussion calls 545 of 13,452 participants 4.2%; this is approximately 4.05%, as correctly shown in Table 3.

    Reported 4.2 · recomputed 4.051442

  • Total-dose confidence interval has two different lower bounds

    Minor

    The study-demographics text gives 388 g as the lower confidence bound for the mean total dose, whereas Table 1 gives 338 g for the same mean and upper bound.

  • Sleep disturbances appear in studies with no affected participants

    Minor

    Table 2 says two placebo studies and four creatine studies reported sleep disturbances. Table 3 reports zero placebo participants and only two creatine participants with sleep disturbances.

5 of 5

Cites

Flagged first, then by citations

Research works printed but not linked: 4

  1. Thelwall M. Social web text analytics with Mozdeh. Wolverhampton: University of Wolverhampton; 2018.
  2. 10.1002/asi.21662 · DOI · Paper page
  3. Cohen J. Statistical power analysis for the behavioral sciences. Lawrence Erlbaum. Hillsdale, NJ; 1988. p. 75–108.
  4. Kreider RB, Klesges R, Lotz D, et al. Effects of nutritional supplementation during off‑season college football training on body composition and strength. J Exerc Physiol Online. 1999;2(2):24–39.

Cited by

Sorted by citations

Authors
Kreider, R. B., Gonzalez, D. E., Hines, K., Gil, A., & Bonilla, D. A.
Affiliations
  • Texas A&M University (US)
  • University of the Basque Country (ES)
Corresponding author
Kreider, Richard B.
Venue
Journal of the International Society of Sports Nutrition
Published
2025-04-08
Volume
22
Issue
sup1
Pages
2488937-2488937
ISSN
1550-2783 (ISSN-L)
OpenAlex
W4409247958
Cited by
29
References
108
Citations by year
2026: 17 · 2025: 12
FWCI
14.37
Type
journal article
Language
en
Open access
Locations
  • Journal of the International Society of Sports Nutrition (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Exercise and Sports Nutrition Lab at Texas A&M University
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Muscle metabolism and nutrition
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutrition and Health Studies
Keywords
creatine supplementation, creatine monohydrate, safety, adverse effects, adverse events, gastrointestinal adverse effects, muscle cramps, adverse event reports, social media sentiment, renal function markers, dietary supplements
MeSH terms
Clinical Trials as Topic, Creatine, Female, Humans, Male, Prevalence, Dietary Supplements, Social Media

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-11-01.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-11-01.

Cited sources are checked by gpt-6-sol.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review